Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3269
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02960646 | Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies | ||
| NCT06326294 | Assessment of the Effectiveness of TA Versus LEEP for Cervical Cancer Risk Reduction in WLHIV in Mozambique | ||
| NCT02410551 | Pacritinib Before Transplant for Myeloproliferative Neoplasms (MPN) | ||
| NCT00112502 | Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme | ||
| NCT01490723 | Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT) | ||
| NCT04859946 | Itacitinib for the Prevention of Graft Versus Host Disease | ||
| NCT00958256 | Study of Bortezomib in Combination With Cyclophosphamide and Rituximab | ||
| NCT05763771 | Smartphone-delivered Scheduled Smoking With Compliance Facilitation as an Adjunct Cessation Therapy: a Feasibility Study | ||
| NCT06184321 | Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion | ||
| NCT01755130 | Laser Optoacoustic and Ultrasonic Imaging System Assembly in Finding Changes in Tumors in Patients With Breast Cancer | ||
| NCT06021600 | A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine | ||
| NCT01301807 | Panobinostat and Carfilzomib in Treating Participants With Relapsed or Refractory Multiple Myeloma | ||
| NCT01548144 | Pazopanib or Pemetrexed and Crizotinib in Advanced Cancer | ||
| NCT06232577 | 5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-abdominal Cancer Surgery: A Randomized Clinical Trial | ||
| NCT02677012 | Autologous Fat Grafting Techniques in Patients Undergoing Reconstructive Surgery | ||
| NCT01198028 | Erlotinib in Treating Patients With Recurrent or Metastatic Skin Squamous Cell Carcinoma | ||
| NCT00698009 | Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory Neuroblastoma | ||
| NCT05143619 | Impact of "Teaching the Teachers" Concept on Global Education and Application of Hepatocellular Carcinoma Diagnosis Guidelines | ||
| NCT00506311 | Evaluating the Use of Fibrin Tissue Adhesive in Melanoma Patients | ||
| NCT00003099 | Chemoprevention Therapy Plus Surgery in Treating Women With Breast Cancer | ||
| NCT02911064 | Expectations Regarding Mobility and Self-Care | ||
| NCT05363709 | BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients | ||
| NCT00490698 | Zoledronate With Atorvastatin in Renal Cell Carcinoma | ||
| NCT02726997 | Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer (N-Dur) | ||
| NCT06066424 | Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA) | ||
| NCT03037346 | Impact of a Systematic Social Work Driven Approach on Medical Power of Attorney Documentation, Knowledge, Attitudes, and Beliefs in Participants With Stage I-IV Gynecological Cancers | ||
| NCT03068624 | Autologous CD8+ SLC45A2-Specific T Lymphocytes With Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma | ||
| NCT00075179 | Natrecor in Pulmonary Hypertension | ||
| NCT01321008 | Stage I/II Nasal NK Cell Lymphoma | ||
| NCT02529813 | CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies | ||
| NCT05634525 | Phase Ib Trial of the KRASG12C Inhibitor Adagrasib (MRTX849) in KRAS G12C Mutant Metastatic Pancreatic Cancer Patients | ||
| NCT01276613 | Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas | ||
| NCT02361320 | Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer | ||
| NCT05535023 | Phase 2 Study of Neoadjuvant SAR444245 Plus Cemiplimab in HPV Related Oropharynx Squamous Cell Carcinoma | ||
| NCT00061620 | Phase I Study of Continuous Infusion Schedule of FMdC in Hematologic Malignancies | ||
| NCT02846623 | Atezolizumab, Obinutuzumab, and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Relapsed or Refractory Richter Syndrome | ||
| NCT07475923 | Molecular Surveillance In Early Breast Cancer Using The Tumor-Informed ctDNA Assay Myriad Genetics Precise MRD Test; A Prospective Observational Multicenter Study (The MRD Molecular Surveillance Study) | ||
| NCT01590732 | Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma | ||
| NCT02719847 | EBUS TBNA After PET/CT in Diagnosing Patients With Stage I-IIA Non-small Cell Lung Cancer Evaluated for Stereotactic Body Radiation Therapy | ||
| NCT00102648 | Lonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Respond to Previous Treatment with Temozolomide | ||
| NCT00494585 | CEP-701 for PH-negative Myelofibrosis | ||
| NCT01471444 | Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) | ||
| NCT02092298 | Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Metastatic Gastric Cancer | ||
| NCT00790452 | Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma | ||
| NCT01454804 | Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors | ||
| NCT00048672 | Therapy of Early Chronic Phase CML With Gleevec | ||
| NCT00317772 | Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer | ||
| NCT02420795 | Akt/ERK Inhibitor ONC201 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | ||
| NCT02113657 | T-Cell Responses to Neoantigens Post Treatment With Ipilimumab in Men With Metastatic Castration-Resistant Prostate Cancer | ||
| NCT00443300 | Effectiveness of Protected Environment Rooms for AML and MDS |
